Abstract COVID-19-associated coagulopathy (CAC) is a life-threatening complication of
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …

In the 3rd year of the SARS-CoV-2 pandemic, much has been learned about the long-term
effects of COVID-19 pneumonia on the lungs. Approximately one-third of patients with …

Background Few studies have analyzed the incidence and the risk of acute myocardial
infarction (AMI) during the post-acute phase of COVID-19 infection. Objective To assess the …

Abstract SARS-CoV-2, the causative agent of COVID-19, primarily affects the epithelial
compartment in the upper and lower airways. There is evidence that the microvasculature in …

Introduction Long-COVID is a broadly defined condition and there are no effective therapies.
Cardiovascular manifestations of long-COVID include high heart rate, postural tachycardia …

Background Extra-hepatic vitamin K-status, measured by dephosphorylated uncarboxylated
matrix Gla protein (dp-ucMGP), maintains vascular health, with high levels reflecting poor …

Background People in low-income countries, especially those with low socio-economic
conditions, are likelier to test positive for SARS-CoV-2. The unequal conditions of public …

Ischemic coronary artery disease in all its forms remains the main cause of death worldwide.
Coronary artery bifurcation lesions are a challenge because of their complexity and possible …

Type 2 diabetes mellitus (T2DM) is a potential risk factor for the development of COVID-19
and is associated with higher severity and mortality rates. T2DM patients are commonly …

Background: Cardiovascular complications contribute to 40% of coronavirus disease 2019
(COVID-19) related deaths. The viral myocarditis associated with COVID-19 accounts for …